3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Uterine Cervical Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Lung Neoplasms
5
Medulloblastoma
4
Neuroblastoma
3
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Oropharyngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Ganglioneuroblastoma
2
Carcinoma, Transitional Cell
2
Brain Neoplasms
2
Vaginal Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Teratoma
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Rhabdoid Tumor
1
Recurrent Uterine Corpus Carcinoma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pathologic Complete Response
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
PRETEXT I Hepatoblastoma
1
Osteosarcoma
1
Interventions
Methotrexate
4
Doxorubicin
3
Ifosfamide
2
Etoposide
2
Cisplatin
2
sodium thiosulfate
1
peginterferon alfa-2b
1
merphos
1
Zoledronic Acid
1
Triptorelin Pamoate
1
Tranexamic Acid
1
Thoracotomy
1
Thoracostomy
1
Thoracoscopy
1
Specimen Handling
1
Sodium Chloride
1
Restraint, Physical
1
Platinum
1
IMVP-16 protocol
1
Granulocyte Colony-Stimulating Factor
1
Fluoridation
1
Filgrastim
1
Fentanyl
1
Docetaxel
1
Cyproheptadine
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Osteosarcoma
×
Platinum
×
Clear all
NCT00134030
2023-06-07
EURAMOS-1
Children's Oncology Group
Phase 3
Completed
1,334 enrolled
17 charts